Follow the 녹십자엠에스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 녹십자엠에스 has logged 23 public disclosures. Market capitalisation: €52.1bn. The latest transaction was reported on 11 March 2026 (Purchase). Among the most active insiders: 녹십자엠에스. The full history is accessible without an account.
22
Insider Decl.
n/a
Thresholds
€5,192
14 ops.
Buy Volume
n/a
1 ops.
Sell Volume
31Σ signal
Buys €5,192n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,156 of 29,063 companies
52.7
score / 100
Value
63
Quality
43
FCF yld3.5%
Earn yld5.5%
EV/EBITDA9.6x
ROE9.9%
Gross mgn14%
Net mgn3.4%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
녹십자엠에스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products and medical devices.